Carregant...
Convalescent plasma to treat coronavirus disease 2019 (COVID‐19): considerations for clinical trial design
Case series studying convalescent plasma use in the treatment of COVID‐19 have been promising, but additional, high‐quality studies are needed to determine the efficacy of the treatment when applied for prophylaxis, for early phases of illness, and for severe illness. Previous studies of convalescen...
Guardat en:
| Publicat a: | Transfusion |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7267607/ https://ncbi.nlm.nih.gov/pubmed/32374891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15843 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|